Bicara Therapeutics Inc. ...
13.27
0.43 (3.39%)
At close: Jan 15, 2025, 11:10 AM

Bicara Therapeutics Inc. Common Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for BCAX stock have an median target of 42, with a low estimate of 35 and a high estimate of 47. The median target predicts an increase of 216.50% from the current stock price of 13.27.

Analyst Consensus: Buy
Target Low Average Median High
Price $35 $41.33 $42 $47
Change 163.75% 211.45% 216.50% 254.18%

AI Analyst Report

According to 5 stock analyst, the rating for Bicara Therapeutics Inc. Common Stock is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.

Rating Oct 24Dec 24
Strong Buy 00
Buy 41
Hold 00
Sell 00
Strong Sell 00
Total 4 1

Financial Forecast this Year

No analyst forecast available for Bicara Therapeutics Inc. Common Stock.